{"id":6052,"date":"2019-12-20T19:22:48","date_gmt":"2019-12-20T16:22:48","guid":{"rendered":"https:\/\/ufuture.com\/?p=6052"},"modified":"2019-12-20T19:22:48","modified_gmt":"2019-12-20T16:22:48","slug":"biopharma-has-become-one-of-the-top-50-innovation-companies-of-ukraine","status":"publish","type":"post","link":"https:\/\/ufuture.com\/en\/biopharma-has-become-one-of-the-top-50-innovation-companies-of-ukraine\/","title":{"rendered":"Biopharma has become one of the Top-50 Innovation Companies of Ukraine"},"content":{"rendered":"<p><a href=\"https:\/\/biopharma.co.uk\/\" target=\"_blank\" rel=\"noopener\">Biopharma<\/a> has become one of the Top-50 Innovation Companies of Ukraine in the Pharmaceuticals category \u2014 the annual rating of the magazine &#8220;TOP-100&#8221;, which the editorial board of the publication makes together with profile experts and readers of the portal <a href=\"https:\/\/delo.ua\/\" target=\"_blank\" rel=\"noopener\">Delo.ua<\/a>. Among the leaders of innovation, experts choose domestic companies that transform their businesses, invest in long-term programs, and experiment with market trends.<\/p>\n<p>Innovative component of Biopharma was the launch of the production of human plasma-derived drugs in 2019. The projected production capacity provides for the possibility of processing up to 1 million liters of plasma per year. The company annually produces about 20 million packs of drugs, some of which are exported to 36 countries.<\/p>\n<p>In the nearest plans of the company \u2014 to enter the TOP-7 fractionators of the world and to enter the market more than fifty countries in total.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biopharma has become one of the Top-50 Innovation Companies of Ukraine in the Pharmaceuticals category \u2014 the annual rating of&#8230;<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts\/6052"}],"collection":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/comments?post=6052"}],"version-history":[{"count":2,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts\/6052\/revisions"}],"predecessor-version":[{"id":6059,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts\/6052\/revisions\/6059"}],"wp:attachment":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/media?parent=6052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/categories?post=6052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/tags?post=6052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}